Detail akcie Evogene online

Business Summary: Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Evogene Ltd revenues decreased 12% to $3.5M. Net loss before extraordinary items decreased 40% to $8.9M. Revenues reflect Agricultural Crops segment decrease of 51% to $901K, Human Health segment decrease from $77K to $0K, Unallocated segment decrease of 13% to $160K, United States segment decrease of 89% to $355K, Europe segment decrease of 58% to $581K, Israel segment decrease of 16% to $258K.